Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Goetz

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2025
Emergent eukaryotic directional sensing via receptor degradation and diffusionAndrew Goetz, Purushottam Dixit
Biorxiv : the Preprint Server for Biology|November 28, 2024
Receptor polarization through localized activity and global sensitizationAndrew Goetz, Purushottam D Dixit
Elife|January 31, 2024
The ability to sense the environment is heterogeneously distributed in cell populationsAndrew Goetz, Hoda Akl, Purushottam Dixit
Biorxiv : the Preprint Server for Biology|March 22, 2023
The ability to sense the environment is heterogeneously distributed in cell populationsAndrew Goetz, Hoda Akl, Purushottam Dixit
Elife|October 29, 2025
Non-equilibrium strategies enabling ligand specificity by signaling receptorsAndrew Goetz, Jeremy Barrios, Ralitsa Radostinova Madsen, et al.
Frontiers in Immunology|May 17, 2024
A global view of T cell metabolism in systemic lupus erythematosusAndrew Goetz, Joy Cagmat, Maigan Brusko, et al.
Crystal Growth & Design|March 25, 2024
Comparison of N···I and N···O Halogen Bonds in Organoiodine Cocrystals of Heterocyclic Aromatic Diazine Mono-<i>N</i>-oxidesClifford W Padgett, Riley Dean, Audrey Cobb, et al.
Cancers|August 29, 2024
Computational Modeling of Drug Response Identifies Mutant-Specific Constraints for Dosing panRAF and MEK Inhibitors in MelanomaAndrew Goetz, Frances Shanahan, Logan Brooks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignanciesBahram Forouzesh, Chris H Takimoto, Andrew Goetz, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanomaAndrew Goetz, Frances Shanahan, Logan Brooks, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2025
Emergent eukaryotic directional sensing via receptor degradation and diffusionAndrew Goetz, Purushottam Dixit
Biorxiv : the Preprint Server for Biology|November 28, 2024
Receptor polarization through localized activity and global sensitizationAndrew Goetz, Purushottam D Dixit
Elife|January 31, 2024
The ability to sense the environment is heterogeneously distributed in cell populationsAndrew Goetz, Hoda Akl, Purushottam Dixit
Biorxiv : the Preprint Server for Biology|March 22, 2023
The ability to sense the environment is heterogeneously distributed in cell populationsAndrew Goetz, Hoda Akl, Purushottam Dixit
Elife|October 29, 2025
Non-equilibrium strategies enabling ligand specificity by signaling receptorsAndrew Goetz, Jeremy Barrios, Ralitsa Radostinova Madsen, et al.
Frontiers in Immunology|May 17, 2024
A global view of T cell metabolism in systemic lupus erythematosusAndrew Goetz, Joy Cagmat, Maigan Brusko, et al.
Crystal Growth & Design|March 25, 2024
Comparison of N···I and N···O Halogen Bonds in Organoiodine Cocrystals of Heterocyclic Aromatic Diazine Mono-<i>N</i>-oxidesClifford W Padgett, Riley Dean, Audrey Cobb, et al.
Cancers|August 29, 2024
Computational Modeling of Drug Response Identifies Mutant-Specific Constraints for Dosing panRAF and MEK Inhibitors in MelanomaAndrew Goetz, Frances Shanahan, Logan Brooks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignanciesBahram Forouzesh, Chris H Takimoto, Andrew Goetz, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanomaAndrew Goetz, Frances Shanahan, Logan Brooks, et al.
Pageof 3